Did the COVID-19 pandemic increase drunkness among people with a history of alcohol use disorder?

How COVID-19-related stressors altered drunkenness frequency.

Genmab acquires ProfoundBio in $1.8bn deal

In April 2024 Genmab and ProfoundBio entered ia definitive agreement to execute the acquisition. Credit: ArDanMe / Shutterstock.com. Genmab has concluded the previously announced acquisition

May 22, 2024

Leveraging scientific excellence to improve investment decisions

To invest is to embrace an unpredictable future, filled with risks and uncertainties. To navigate this uncertainty, which sits atop a complex and ever-changing market

July 29, 2024

Almirall and EpimAb partner to develop bispecific antibody therapies – Pharmaceutical Technology

EpimAb’s FIT-Ig platform rearranges the DNA sequences of two monoclonal antibodies to generate bispecific antibodies. Image Credit: Gorodenkoff/Shutterstock. Almirall has signed a licensing agreement with

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.